Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Faegheh Ebrahimi Chaharom"'
Autor:
Faegheh Ebrahimi Chaharom, Ali Asghar Ebrahimi, Faroogh Feghhi Koochebagh, Zohreh Babalou, Morteza Ghojazadeh, Leili Aghebati Maleki, Nader D. Nader
Publikováno v:
Immunological Medicine, Vol 46, Iss 4, Pp 175-181 (2023)
AbstractThe current study aims to investigate the relationship betweSen serum IL-17 (IL-17) levels and systemic lupus erythematosus disease activity index (SLE-DAEI) in systemic lupus erythematosus (SLE) patients. In this case-control study, 36 patie
Externí odkaz:
https://doaj.org/article/4c7e8a0c768a4257ad2912f519595084
Autor:
Aliasghar Ebrahimi, Mehrzad Hajialiloo, Sepideh Tahsini Tekantapeh, Pouya Vakilipour, Faegheh Ebrahimi Chaharom
Publikováno v:
Rheumatology & Autoimmunity, Vol 4, Iss 2, Pp 129-130 (2024)
Externí odkaz:
https://doaj.org/article/d33ae4687379483aaeed8f5f07787891
Autor:
Mansour Hosseini, Hamidreza Moussavi, Hadi Karimzadeh, Mohammadreza Shakibi, Mohammad Ali Nazarinia, Farhad Gharibdoost, Amirhossein Salari, Mansour Karimifar, Faegheh Ebrahimi Chaharom, Zahra Mirfeizi, Karim Mowla, Nassim Anjidani, Mansour Salesi, Maryam Sahebari, Peyman Mottaghi, Ahmadreza Jamshidi
Publikováno v:
Advances in Therapy. 38:1290-1300
Phase IV post-marketing surveillance studies are needed to evaluate the real-world safety and effectiveness of drug products. This study aimed to evaluate the safety and effectiveness of biosimilar etanercept (Altebrel, AryoGen Co., Iran) in patients
Publikováno v:
Pulmonary Pharmacology & Therapeutics
Background Covid-19 disease is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Although corticosteroids have shown some promising results in Covid-19 patients, their effectiveness remains controversial. In this systematic revi